See 4Degra™ at Med-Tech Expo at NEC, Birmingham, UK, 28/29 September (Stand C59)

4D Biomaterials is delighted to announce the world’s first public appearance of the 4Degra™ product range at the UK’s foremost Med-Tech trade event. Our team will be demonstrating the ground-breaking performance of 3D printed structures made with 4Degra™ and showing examples of the implantable medical devices that are being developed from them. We look forward

Read more

4D Biomaterials completes £1.6m ($2.2m) seed round

4D Biomaterials has just completed a £1.6m ($2.2m) seed investment round led by DSW Ventures and backed by the MEIF Proof of Concept and Early Stage Fund which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s own funds, and existing investor SFC Capital. The company’s leading product 4Degra™ can be

Read more

Where to see us in 2021

4D Biomaterials – so what’s new? An interview with Phil Smith is featured on the 3D Medtech Printing Conference website, read the interview here 3D Medical Printing Series: LinkedIn View the LinkedIn Event Activity here Facebook Activity View the Facebook Event Activity here 4D Biomaterials is introducing a new class of 3D printing resin-inks for

Read more

Seed Investment Opportunity

Are you looking to invest in disruptive new MedTech technology with the potential to become a substantial medical device/materials business? Building on the rapid progress made in our first nine months of operation, we are now seeking seed investment of £1m that will enable the company to hit the next set of milestones on our

Read more

Press Release July 2020

Universities of Birmingham and Warwick form spinout company, 4D Medicine Ltd, to take new family of biomedical 3D printing resins to market

Read more